Terumo BCT is dedicated to helping our customers save lives through innovation, quality and services delivered by our people, products and processes in blood component technologies. Unlocking the potential of blood depends largely on our ability to develop and maintain the trust of our customers, donors and the patients who rely on our products and services. We also strive to maintain the confidence of Terumo Corporation, our customers and the patients they serve, associates and government authorities. To this end, Terumo BCT upholds our Code of Conduct and SAKURA Rules that:
-
Embody a fundamental expression of professionalism
-
Exemplify personal integrity
-
Represent policies and guidelines for relationships with associates and others
-
Are requirements for compliance and training by each associate to ensure continued success
Terumo BCT maintains a Compliance Program that reflects the principles outlined in the Terumo BCT Code of Conduct. The program also includes applicable codes of ethics issued by our primary trade associations, the government standards and anti-corruption laws we follow, and guidelines for how to communicate customer concerns.
Terumo BCT Code of Conduct (English)
Terumo BCT Code of Conduct (German)
Terumo BCT Code of Conduct (Spanish)
AdvaMed Code of Ethics
Eucomed Code of Ethics
1. Terumo BCT is a member of the Advanced Medical Technology Association (AdvaMed) and complies with the Revised Code of Ethics developed by AdvaMed for interactions with health care professionals in the U.S.
2. Terumo BCT is a member of Eucomed and follows the Eucomed Code of Business Practice for interactions with health care professionals in Europe
3. Terumo BCT adheres to codes within Latin America established by the Argentine Center for Materials Research and Testing (CADIEM), the National Chamber of Pharmaceutical Industries (CANIFARMA) in Mexico, and the Brazilian Association of Importers of Medical Equipment, Products, and Supplies (ABIMED)
4. Terumo BCT complies with Japanese Sarbanes Oxley requirements and follows the Japanese Fair Competition Code of Medical Devices Industry and the Fair Competition Code of the Ethical Pharmaceutical Drugs Marketing Industry